Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
First Affiliated Hospital of Zhejiang University
Fudan University
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Queensland Centre for Gynaecological Cancer
Mayo Clinic
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sixth Affiliated Hospital, Sun Yat-sen University
University of Utah
St. Antonius Hospital
University Hospital, Montpellier
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
UNC Lineberger Comprehensive Cancer Center
St. Antonius Hospital
First Affiliated Hospital of Zhejiang University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences